ATYPICAL FEMORAL FRACTURES AFTER TREATMENT WITH BISPHOSPHONATES AND DENOSUMAB IN INFLAMMATORY AND SENILE OSTEOPOROSIS

被引：1
|
作者：
Melendez, L. Merino [1 ]
Llorente, I. [1 ]
Garcia, E. [1 ]
Garcia-Vicuna, R. [1 ]
Sanz, S. Castaneda [1 ]
机构：
[1] Hosp Univ la Princesa, Rheumatol, Madrid, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.5000
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0288
引用
收藏
页码：762 / 763
页数：2
相关论文
共 50 条
  • [41] Bisphosphonates after denosumab withdrawal reduce the vertebral fractures incidence
    Grassi, Giorgia
    Chiodini, Iacopo
    Palmieri, Serena
    Cairoli, Elisa
    Arosio, Maura
    Eller-Vainicher, Cristina
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 185 (03) : 387 - 396
  • [42] ATYPICAL FEMORAL FRACTURES ASSOCIATED WITH SHORT-TERM EXPOSURE TO DENOSUMAB
    Chandran, M.
    Tay, D.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S381 - S381
  • [43] Bilateral atypical femoral fractures in a patient prescribed denosumab - A case report
    Thompson, Robin N.
    Armstrong, Ciara L.
    Heyburn, Gary
    BONE, 2014, 61 : 44 - 47
  • [44] Atypical femoral fractures bilaterally in a patient receiving denosumab - a case report
    Drampalos, Efstathios
    Skarpas, George
    Barbounakis, Nikos
    Michos, Ioannis
    ACTA ORTHOPAEDICA, 2014, 85 (01) : 3 - 5
  • [45] Alendronic acid/denosumab/methylprednisoloneBilateral atypical femoral fractures: case report
    Reactions Weekly, 2014, 1527 (1) : 19 - 19
  • [46] Are Bisphosphonates Associated With an Increased Risk of Atypical Femoral Fractures as a Class? Reply
    Meier, Raphael P. H.
    Rizzoli, Rene
    Peter, Robin E.
    JAMA INTERNAL MEDICINE, 2013, 173 (01) : 80 - 80
  • [47] Bisphosphonates/Zoledronic-acidBilateral atypical femoral fractures and lack of efficacy
    Reactions Weekly, 2024, 2002 (1) : 101 - 101
  • [48] Bisphosphonates and atypical femoral fractures: Is the location of the fracture associated with the time of consolidation?
    Llano, Lionel
    Barla, Jorge
    Taype, Danilo
    Garcia Barreiro, Gonzalo
    Sancineto, Carlos
    Carabelli, Guido
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2023, 54
  • [49] Denosumab versus Bisphosphonates for Reducing Fractures in Postmenopausal Women with Osteoporosis: A Meta-Analysis
    Thal, Karissa A.
    Nudy, Matthew
    Moser, Eileen M.
    Foy, Andrew J.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2023, 36 (01) : 175 - +
  • [50] Osteonecrosis of the jaw in patients transitioning from bisphosphonates to denosumab treatment for osteoporosis
    P. J. Voss
    D. Steybe
    P. Poxleitner
    R. Schmelzeisen
    C. Munzenmayer
    H. Fuellgraf
    A. Stricker
    W. Semper-Hogg
    Odontology, 2018, 106 : 469 - 480
12345